| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
2 companies
Una S Ryan is Director at RNXT, with reported holdings spanning 2 companies. Una S Ryan's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $217K at current prices.
Una S Ryan's largest disclosed position is in RNXT as Director, worth about $125K.
Una S Ryan has 15 Form 4 filings on record from May 2019 to October 2026, across 2 companies: Director at RenovoRx (RNXT), 2021–2026; Quince Therapeutics (QNCX), 2019–2025.
The 18 reported transactions were 13 option or other derivative awards, 4 other transactions and 1 open-market purchase.
Counted by filing, the open-market trades come to 1 purchase worth about $49K and no sales.
The only open-market purchase was 2,875 shares of QNCX at an average $17.00 on May 13, 2019, about $49K.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 13, 2019 | QNCX Quince Therapeutics, Inc. | Director | Buy | 2,875 | $17.00 | $48,875.00 | New |